Stocks · News reference

Reported Earlier, TRexBio Prices Initial Public Offering Of 8,333,334 Common Shares At $14.00 Each For About $116.7M Gross Proceeds

Oct 9, 2026, 6:56 AMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaOct 16, 2026, 8:23 PMBenzinga Newsdesk
Eli Lilly Takes 19.9% Stake In TRex Bio With 5.48M Shares, Investing $12.3M In IPO
The Reporting Person beneficially owns an aggregate of 5,480,872 shares of Common Stock of the Issuer, consisting of (a) 2,510,411 shares of Common Stock that were issued to the Reporting Person upon conversion of
LLY TRXB
SEC EDGAROct 13, 2026, 8:56 PMSEC EDGAR
8-K filing — TRex Bio, Inc. (TRXB)
Filed: 2026-10-13 AccNo: 0001193125-26-420588 Size: 440 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
TRXB
BenzingaOct 9, 2026, 2:10 PMBenzinga Newsdesk
Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO security released for quotation
TRXB